Entecavir

Red

Brand Name(s):Baraclude

Indication:Chronic hepatitis B infection in adults with decompensated liver disease

Rationale:1,2,8

Considered:Oct-06

Review Date:Jun-23

Comments:
NICE CG165 can be found at: http://www.nice.org.uk/nicemedia/live/14191/64234/64234.pdf
Issued: June 2013
…………………………
Entecavir, within its marketing authorisation, is recommended as an option for the treatment of people with chronic HBeAg-positive or HBeAg-negative hepatitis B in whom antiviral treatment is indicated.